Zenith Drugs expands distribution network in Uttar Pradesh

0 min read Updated on 26 May 2026, 09:55 AM

Reviewed by

Jubin VScanX News Team

AI Summary

Zenith Drugs Limited expanded its distribution network with the launch of a Mother Depot in Uttar Pradesh on May 25, 2026. The move aims to strengthen market presence and improve supply chain efficiency in the region.

*this image is generated using AI for illustrative purposes only.

Zenith Drugs Limited expanded its distribution network with the launch of a Mother Depot in Uttar Pradesh on May 25, 2026. The strategic move aims to strengthen the company's market presence and improve supply chain efficiency in the region.

The launch was conducted under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework mandates timely disclosure of material events to ensure transparency for shareholders.

Strategic Expansion

The establishment of the Mother Depot is expected to facilitate better inventory management and faster delivery times to distributors and retailers in Uttar Pradesh. This expansion aligns with the company's objective to enhance its operational footprint across key markets.

Operational Details

The new depot will serve as a central hub for storage and logistics, enabling Zenith Drugs to cater to the growing demand for its pharmaceutical products in the region. The initiative reflects the company's commitment to optimizing its distribution capabilities.

Historical Stock Returns for Zenith Drugs

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+3.99%	-8.25%	+4.38%	-21.91%	-39.21%	-60.34%

Will Zenith Drugs replicate this Mother Depot model in other key regions to further expand its national footprint?

How will this distribution enhancement impact the company's revenue growth and market share in Uttar Pradesh over the next fiscal year?

What specific inventory management technologies will be implemented at the new depot to ensure operational efficiency?

Read Next Article

Zenith Drugs wins Rs 3.93 crore Karnataka tender

1 min read Updated on 26 May 2026, 03:09 AM

Reviewed by

Jubin VScanX News Team

Add as a preferred
source on Google

AI Summary

Zenith Drugs Limited secured a Rs 3.93 Crore tender from Karnataka State Medical Supplies Corporation Limited for supplying Oral Rehydration Salts. The order covers 16,388,432 units and strengthens the company's institutional business presence. The disclosure was made under Regulation 30 of SEBI LODR Regulations, 2015.

*this image is generated using AI for illustrative purposes only.

Zenith Drugs Limited has secured a significant order worth Rs 3.93 Crore from Karnataka State Medical Supplies Corporation Limited to supply pharmaceutical products. The contract, awarded in the normal course of business, involves the supply of Oral Rehydration Salts IP 20.5 gm (1x1 sachet). This development reinforces the company's presence in the institutional pharmaceutical supply segment and underscores the confidence of government healthcare agencies in its product quality and execution capabilities.

The order details were disclosed to the National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that this transaction does not fall under related party transactions. Execution of this order is anticipated to enhance the company's revenue visibility and deepen its engagement with public healthcare institutions.

Order Details

Parameter	Details
Name of Authority	Karnataka State Medical Supplies Corporation Limited
Nature of Contract	Supply of pharmaceutical product
Product	Oral Rehydration Salts IP 20.5 gm (1x1 sachet)
Quantity	16388432
Order Value	approx. Rs. 3.93 Crore

The communication was addressed to the Listing Compliance Department of the exchange and signed by Sakshi Bhawsar, Company Secretary & Compliance Officer of Zenith Drugs Limited.

Historical Stock Returns for Zenith Drugs